DRUGS MADE IN AMERICA ACQUIS (DMAA) Stock Income Statement
NASDAQ:DMAA • KYG2847J1040
Current stock price
10.47 USD
0 (0%)
Last:
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | ||||
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 1.01M | 279.90K | N/A | |||
| Selling, General, and Administrative Expenses | 1.01M | 279.90K | N/A | |||
| Operating Income | -1.01M | -279.90K | 0.00 | |||
| Income Before Taxes | 5.45M | -279.90K | N/A | |||
| Net Income | 5.45M | -279.90K | N/A | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | 0.20 | -0.01 | N/A | |||
| Statistics | ||||||
All data in USD